Articles

Billions of dollars now committed to home-testing masses of people could be saved if we tested only the symptomatic. Those funds would be better spent supporting access to affordable COVID treatment for people with a high risk of hospitalization.

Editor’s note: This story was first published by The Orange County Register on December 30, 2021 and written by Claudia Boyd-Barrett. Amparo Miramontes and her husband thought they’d found the perfect place to raise a family when they moved with their baby daughter from Burbank to Fontana in 2010. They bought a spacious, five-bedroom home for […]

Over the past year, Schaeffer Center experts authored over 130 journal articles and 14 white papers. They were also in the media about 5,500 times, including authoring over 40 op-eds and blog posts. Below is a look back at a few of the most impactful studies from 2021.

With the No Surprises Act set to take effect January 1, HHS is resisting a push from some doctor groups to weaken implementation rules of the legislation, and that’s a good thing. The law is a big win for patients, employers, and consumers.

While all states and D.C. have adopted at least one policy related to treatment access for patients suffering from opioid addiction, no state adopted all the policies analyzed, leaving potential barriers in place.

Congress should take advantage of the current political climate and start reining in the intermediaries in the drug distribution system.

Pilot funding amounts range from $25,000 to up to $45,000. An informational session on the application process will be held over zoom on Thursday, December 9, 2021, at 10:00 a.m. pacific. 

Schaeffer research offers one of the most comprehensive looks at the insulin distribution chain and shows which players are profiting, and by how much, from selling insulin.

Social vulnerability was also independently associated with widening disparities in county-level coverage, signaling the need for unique, targeted interventions.